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Background: On the basis that high fat diet induces inflammation in adipose tissue, we wanted to test the effect
of dietary saturated and polysunsaturated fatty acids on human adipose tissue and adipocytes inflammation.
Moreover we wanted to determine if TLR2 and TLR4 are involved in this pathway.
Methods: Human adipose tissue and adipocytes primary cultures were treated with endotoxin-free BSA conjugated
with SFA (lauric acid and palmitic acid - LA and PA) and PUFA (eicosapentaeneic acid, docosahexaenoic acid and
oleic acid - EPA, DHA and OA) with or without LPS. Cytokines were then assayed by ELISA (TNF-alpha, IL-6 and
MCP-1). In order to determine if TLR2 and TLR4 are activated by fatty acid (FA), we used HEK-Blue cells transfected
by genes from TLR2 or TLR4 pathways associated with secreted alkaline phosphatase reporter gene.
Results: None of the FA tested in HEK-Blue cells were able to activate TLR2 or TLR4, which is concordant with the
fact that after FA treatment, adipose tissue and adipocytes cytokines levels remain the same as controls. However,
all the PUFA tested: DHA, EPA and to a lesser extent OA down-regulated TNF-alpha, IL-6 and MCP-1 secretion in
human adipose tissue and adipocytes cultures.
Conclusions: This study first confirms that FA do not activate TLR2 and TLR4. Moreover by using endotoxin-free
BSA, both SFA and PUFA tested were not proinflammatory in human adipose tissue and adipocytes model. More
interestingly we showed that some PUFA exert an anti-inflammatory action in human adipose tissue and
adipocytes model. These results are important since they clarify the relationship between dietary fatty acids and
inflammation linked to obesity.
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Recent decades, overnutrition-related diseases are in-
creasing in developed countries due to inappropriate
diets. Indeed high fat diet regulates some metabolic dys-
functions which lead to low grade inflammation, long
before the onset of overweight and obesity [1]. Specific-
ally it has been shown that high fat diet leads to hyper-
trophy and inflammation in adipocytes [2,3], which
release proinflammatory cytokines and free fatty acids* Correspondence: laurence.hoareau@adipsculpt.com
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distribution, and reproduction in any mediumvia lipolysis [4]. These circulating free fatty acids
released into plasma through lipoproteins, specifically
saturated fatty acids trigger inflammation within adipose
tissue [5] and set the platform for the emergence of car-
diovascular diseases such as atherosclerosis [6,7]. This
led researchers to study the inflammatory properties of
various fatty acids. It is thus well proved in numerous
cell types and animal models that polyunsaturated fatty
acids (PUFA) exhibit protective effect on health by
diminishing the secretion of proinflammatory cytokines
[8-11] while on the other hand saturated fatty acids
(SFA) promote inflammation by increasing secretion of
proinflammatory cytokines [12-14].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.lipidworld.com/content/11/1/175As adipose tissue is a major reservoir for fatty acids, it
is particularly interesting to know the exact effect of
fatty acids specifically on this particular tissue. Moreover
adipose tissue is highly involved in chronic low grade in-
flammation [15-17] by the recruitment of macrophages
and also by secreting proinflammatory cytokines such as
TNF-alpha, IL-6 and chemokines such as MCP-1 col-
lectively referred as adipokines [17]. For many years the
principal cells of this tissue, mature adipocytes, were
underestimated in their role in inflammation and the
work of our team has reinforced the idea that these cells
are largely responsible for low grade inflammation [18].
Indeed adipocytes are able to secrete various kinds of
cytokines long before the infiltration of macrophages
and some of these cytokines are secreted at higher levels
compared to macrophages. In addition it has been
proved that this inflammation is mediated in part by the
presence of TLR2 and TLR4 on adipocytes [18].
Confrontation of several studies leads to think that
SFA could induce inflammation through TLR2/4 by
leading to secretion of proinflammatory cytokines in a
dose-dependent manner in different cells such as
RAW264.7 [5,19], THP-1 [6,20], dendritic cells [21] and
3T3-L1 adipocytes [12]. Although these studies do not
show a direct link between SFA and TLR2/4, it is quite
possible since the extracellular domain of TLRs includes
a leucine rich repeat (LRR) region which allows the asso-
ciation with hydrophobic ligands such as fatty acids, for
example [22]. However, these data are controversial
since Erridge and Sammani [23] have proved that this
fatty acids mediated inflammation is due to endotoxin
contaminants present in the BSA used to complex fatty
acids. This raises a question on all data concerning theFigure 1 TLR2 and TLR4 activation by fatty acids. HEK-Blue-2 (panel A)
BSA (1.25 and 2.5 μM), PUFA : EPA, DHA and OA (5 and 10 μM), SFA : PA and
Pam3Cys (10 ng/ml) were used as positive control for HEK-4 and HEK-2 cells r
show the mean ± SD of the results of 2 experiments (n=12 for each conditionsignalling pathway of dietary fatty acids. Thus the pur-
pose of this study is to determine the inflammatory role
of dietary and endotoxin free PUFA and SFA on human
adipose tissue in primary culture. We determined
whether this effect is specifically mediated by mature
adipocytes isolated from this tissue and through this
study we aim to confirm the involvement of TLR2 and
TLR4 in this process.Results
TLR2 and TLR4 activation by fatty acids
In order to determine if fatty acids can activate TLR and
also to test the possible presence of endotoxin in the
BSA or media used for the experiments, we tested
medium 199 with BSA on transfected HEK-293 cells
(Figure 1). We could not detect activation of TLR2 and
TLR4 on the HEK-2 (Figure 1A) and HEK-4 (Figure 1B)
cells which cleared any doubt about possible presence of
any endotoxin in the experimental set up. Based on this,
we checked if SFA such as palmitic acid (PA) and lauric
acid (LA) have the ability to activate TLR2 and TLR4.
Our results show that both PA and LA did not lead to
sAP activation which means that they do not activate
TLR4 nor TLR2. Next we tested PUFA such as DHA,
EPA and OA on both HEK-2 and HEK-4 to determine
whether they could activate TLR2 and TLR4. Interest-
ingly none of the fatty acids that we have used in our
experiments was able to activate neither TLR2 nor
TLR4. Treatment of HEK-2 and HEK-4 cells by
Pam3Cys and LPS, natural ligands for TLR2 and TLR4
respectively, led to sAP activation which further vali-
dates the model.and HEK-Blue-4 cells (panel B) were treated with medium (control),
LA (40 and 100 μM), for 16 and 20 hours respectively. LPS (10 ng/ml) and
espectively. Results have been normalized to control (1 unit). The graphs
).
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adipose tissue and adipocytes
In order to check whether dietary free fatty acids (SFA
and PUFA) can promote inflammation on human adi-
pose tissue and mature adipocytes, cytokines such as IL-Figure 2 (See legend on next page.)6, TNF-alpha and MCP-1 were measured from the
media after incubation with BSA conjugated fatty acids.
In Figure 2, we can see that levels of IL-6, TNF-alpha
and MCP-1 in media after incubation with PUFA and
SFA remained same as the negative controls (incubation
(See figure on previous page.)
Figure 2 Proinflammatory effects of SFA and PUFA on human adipose tissue and adipocytes. A and B: IL-6 secretion in the medium of
adipose tissue (A) and adipocytes (B) culture after treatment with PUFA and SFA for 12 hours with LPS (1 μg/ml) as positive control. Results
were expressed in arbitrary units normalised to control (1 represents from 15 to 20 ng/ml IL6, depending on the patient). The graph shows the
mean ± SD of the results from 4 patients (n=6 for each condition, for each patient). C and D: TNF-alpha secretion in the medium of adipose
tissue (C) and adipocytes (D) after treatment with PUFA and SFA for 6 hours, with LPS (1 μg/ml) as positive control. Results were expressed in
arbitrary units, normalised to control (1 represents from 0.02 to 0.05 ng/ml TNF-alpha, depending on the patient). The graph shows the mean ±
SD of the results from 4 patients (n=6 for each condition, for each patient). E and F: MCP-1 secretion in the medium of adipose tissue (E) and
adipocytes (F) after treatment with PUFA and SFA for 12 hours, with LPS (1 μg/ml) as positive control. Results were expressed in arbitrary units,
normalised to control (1 represents from 10 to 15 ng/ml MCP-1, depending on the patient). The graph shows the mean ± SD of the results from
3 patients (n=6 for each condition, for each patient).
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and SFA were not able to induce inflammation in adi-
pose tissue nor specifically in adipocytes. These results
are in accordance with the previous results from HEK-
Blue cells which further confirms no activation of TLR2
and TLR4.Anti-inflammatory effects of PUFA on human adipose
tissue and adipocytes
It has been reported that PUFA such as DHA and EPA
showed anti-inflammatory effects on LPS induced 3T3-L1
adipocytes [24] and macrophages [8,11]. Then in order to
check the anti-inflammatory effect of PUFA, adipose tis-
sue and adipocytes were co-incubated with LPS and either
DHA, EPA or OA (Figure 3). Interestingly the co-
incubation with DHA or EPA led to down regulation of
LPS induced cytokine secretion in both adipose tissue and
mature adipocytes models. This down regulation was not
due to cell death (data not shown). EPA showed signifi-
cant anti-inflammatory effects by reducing 30% IL-6
(Figure 3A), 50% TNF-alpha (Figure 3C) and 45% MCP-1
(Figure 3E) secretion compared to LPS treatment in
adipose tissue while, in mature adipocytes, it reduced 40%
IL-6 (Figure 3B), 45% TNF-alpha (Figure 3D) and 55%
MCP-1 (Figure 3F) secretion. DHA treatment reduced
40% IL-6 (Figure 3A), 20% TNF-alpha (Figure 3C) and
30% MCP-1 (Figure 3E) secretion in adipose tissue and
45% IL-6 (Figure 3B), 15% TNF-alpha (Figure 3D)
and 45% MCP-1 (Figure 3F) secretion in mature adipo-
cytes. OA reduced IL-6 and MCP-1 secretion in a non-
significant way, in both adipose tissue and adipocytes
(Figure 3A/B/E/F) and no significant change was noticed
in case of TNF-alpha (Figure 3C/D).
Discussion
Controversial data are available regarding the proinflam-
matory and anti-inflammatory role of dietary free fatty
acids. It has been shown that mice fed with SFA rich diet
are prone to inflammation and promotes insulin resist-
ance and atherosclerosis. Also this SFA mediated inflam-
mation was attenuated in TLR4 and TLR2 knock out
studies [25-29] and this leads to the suggestion that SFApromote inflammation via direct activation of TLR2 and
TLR4. Many research groups have claimed that PA and
LA directly stimulate TLR2/4 [30,31] and induce secre-
tion of proinflammatory cytokines in different cell
models such as macrophages, endothelial cells and adi-
pocytes. Recently Erridge and Samani [23] have shown
that SFA mediated TLR2/4 activation is mainly due to
the LPS and other lipopeptide contamination present in
the BSA used for experimental setup. This creates doubt
in the whole understanding of fatty acid mediated in-
flammation in different cell lines and animal models. In
our previous work, we have shown the presence of func-
tional TLR2/4 in adipocytes which were able to respond
to TLR2 and TLR4 ligands (LTA and LPS respectively)
by secreting TNF-alpha in a dose dependent manner
[18]. Therefore in this present study we aimed to analyze
the effect of fatty acids directly on the primary culture of
human adipose tissue and mature adipocytes.
From our work, we showed that none of the fatty acids
including saturated FA: PA and LA at the concentration
of 40 and 100 μM were able to induce inflammation on
primary culture of human adipose tissue and mature
adipocytes. This has been confirmed by analyzing the
three most important cytokines such as TNF-alpha, IL-6
and MCP-1 which are secreted by adipose tissue during
inflammation. Our results are in contradiction with
those from many studies regarding the inflammation
induced by PA and LA. The first reason could be the
concentrations of FFA used for the experiment. Indeed
in those previous studies, PA and LA concentrations
used were higher: in the range of 0.25-0.5 mM for
3T3-L1 adipocytes [12,32,33], myotubes [34], or CAEC’s
[35] treatment. We used PA and LA at 100 μM, which is
in accordance with many recent studies [36]. However
in our study, even at high concentrations (more than
100 μM, data not shown) no inflammatory effect could
be observed on primary culture of mature adipocytes
and adipose tissue. The second reason and probably the
main reason for the inflammation induced by PA and
LA in the earlier studies is the LPS and other lipopeptide
contaminants present in the BSA used for fatty acid con-
jugation. Indeed Erridge and Samani [23] have previ-
ously shown that lipopeptide contaminants are present
Figure 3 Anti-inflammatory effects of PUFA on human adipose tissue and adipocytes. Adipose tissue (A, C, E) and adipocytes (B, D, F)
were treated with 1 μg/ml LPS with or without PUFA (EPA, DHA and OA) at the concentration of 5 and 10 μM. A and B: IL-6 secretion was measured
in media by ELISA after 12 hours treatment. Results were expressed in arbitrary units, normalised to LPS (1 represents from 0.3 to 0.5 μg/ml IL6 -
adipose tissue, and 0.05 to 0.1 μg/ml - adipocytes, depending on the patient). C and D: TNF-alpha secretion was measured in media by ELISA after
6 hours treatment. Results were expressed in arbitrary units, normalised to LPS (1 represents from 3 to 5 ng/ml TNF-alpha - adipose tissue, and 0.5 to
1 ng/ml - adipocytes, depending on the patient). E and F: MCP-1 secretion was measured in media by ELISA after 12 hours treatment. Results were
expressed in arbitrary units, normalised to LPS (1 represents from 0.1 to 0.25 μg/ml MCP-1 - adipose tissue, and 0.08 to 0.14 μg/ml - adipocytes,
depending on the patient). The graphs show the mean ±SD of the results from 8 patients (n=6 for each condition, for each patient).
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they have demonstrated that SFA conjugated with BSA
(LPS and lipopeptide free) do not induce inflammation.
For this reason, we used fatty acid poor and endotoxin
free BSA all along the work. We confirmed the absence
of endotoxin in our media or BSA used by testing withHEK-Blue cells on which TLR4 and TLR2 are activated
even with a low amount of LPS and Pam3Cys respect-
ively. Also we tested the BSA conjugated SFA and PUFA
on HEK-2 and HEK-4 and we found that none of the
fatty acids are able to activate HEK-4 or HEK-2 cells.
This proves that even if SFA are able to induce
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through TLR2 nor TLR4 activation. Our results are simi-
lar to Erridge [23], who demonstrates that PA and LA
alone are not able to induce inflammation. Recently
Chang [13] has shown in RAW264.7 cells that pre-
treatment with PA but not LA increased the LPS
induced proinflammatory mediators such as TNF-alpha
and IL-6, while he could not detect any inflammatory ef-
fect of PA alone. This means that PA could act as an ad-
juvant to potentiate TLR4 activation by LPS. Personnal
data from Schwartz on the same model contradict this
idea, whereas they confirm Chang’s conclusion on
human monocytes (THP-1), which proves that species
and cell types have to be consider when we compare
data [36]. Recently a new circulating hepatic glycopro-
tein: fetuin-A, was correlated with obesity and associated
pathologies [37-39]. This protein was found to be a
required endogeneous TLR4 ligand and also crucial for
the interaction of FFA with TLR4, permiting FFA pro-
inflammatory effect through TLR4-pathway [40] which
further supports our results. Thus on the basis of our
results, we confirmed that no proinflammatory effect
was induced by free fatty acids alone especially SFA on
adipose tissue and mature adipocytes.
Moreover, we confirmed here that PUFA, like EPA,
DHA and OA have anti-inflammatory properties. Fur-
thermore EPA was found to have greater anti-
inflammatory effect compared to DHA in both adipose
tissue and mature adipocytes. OA was also found to
have some anti-inflammatory effect to some extent but
not comparable to EPA and DHA. These anti-
inflammatory effects are in accordance with the previous
studies on different cells such as RAW264.7 [13,41],
THP-1 [11], HIMEC [10] and animal models [42,43]. In
murine 3T3-L1 adipocytes it has been also shown that
EPA and DHA are able to reduce MCP-1 expression and
NFkB translocation [33]. Recently Oliver et al., [24] have
shown in 3T3-L1 adipocytes and in macrophages that
DHA has greater anti-inflammatory effect compared to
EPA by attenuating the LPS induced NFkB activation
and TNF-alpha secretion. This anti-inflammatory effect
could be due to the activation of an alternate pathway
through TLR4 [44] which is not NFkappaB-dependant
or by a modulation of the LPS/TLR4 binding [45],
through changes in lipid rafts for instance [46]. In our
study, we showed that down regulation of LPS-induced
cytokines secretion with DHA and EPA occurs in both
models: adipose tissue and mature adipocytes. From this,
we can hypothesize that mature adipocytes are more re-
sponsive to PUFA compared to other cells in the adipose
tissue. This can be explained by the fact that in adipose
tissue from normal BMI individuals, mature adipocytes
are highly involved in inflammation process, in terms of
high cytokine levels they are able to secrete and in termsof the number of these cells within the tissue [47]. How-
ever under inflammation (LPS-treatment) we can’t omit
that stromal vascular cells can also be involved in this
secretion by acting in a synergestic way with adipocytes.
Indeed stromal vascular cells from obese patients show
an up-regulation in inflammation-related genes [48].
Evidences suggest that these anti-inflammatory effects
by PUFA are due to the conversion of these fatty acids
into N-acyl ethanolamines (NAE), resolvins [22] and
eicosanoids [49]. Balvers et.al., [9] have shown in 3T3-L1
adipocytes that N-Acyl ethanolamine (NAE) such as
DHEA and EPEA can be synthesized directly from their
fatty acids precursors DHA and EPA respectively,
through the transfer of fatty acid from membrane bound
phospholipids to phosphatidylethnaolamine (PE) to form
N-acyl phosphatidylethanolamine (NAPE). Then NAPE
specific phospholipase D cleaves NAPE to their respect-
ive NAE [50]. Balvers et al., [9] have further shown that
these DHEA and EPEA act via PPAR-γ and CB2 recep-
tors for their anti-inflammatory properties. However, our
team has previously shown that the anti-inflammatory
effect of palmitoylethanolamide, the NAE synthesized
from palmitic acid, is independent of CB1 and CB2
receptors on human mature adipocytes [49]. It is there-
fore difficult with current data, to accurately determine
the mechanisms involved in the anti-inflammatory
effects of these molecules.Conclusions
The inflammatory role and pathway of fatty acids are
controversal for many years. Here we show that neither
SFA nor PUFA have a pro-inflammatory effect on
human adipose tissue and adipocytes as there are not
able to activate TLR2 and TLR4. Moreover we show that
PUFA have an anti-inflammatory effect, probably inde-
pendent of TLRs on adipose tissue and especially on ma-
ture adipocytes. Finally, these results confirm the
marked involvement of adipocytes in the relationship be-
tween dietary fatty acids and inflammation linked to
obesity.Methods
Reagents
Lipopolysaccharides (LPS from E. coli 0111:B4 strain,
batch #LPE-32-02) was purchased from Sigma (Saint
Quentin Fallavier, France), Pam3Cys (Catalog # tlrl-pmc)
from InvivoGen, BSA (Fraction V, fatty acid poor and
endotoxin free) from Calbiochem, Cat # 126579. Doco-
sahexaenoic acid (DHA), eicosapentaeneic acid (EPA),
palmitic acid (PA), oleic acid (OA) and lauric acid (LA)
were purchased from Cayman chemicals and resus-
pended in DMSO and stored at -20°C for experiments.
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HEK-Blue™ LPS Detection Kit and PlasmoTest™ were
purchased from Invivogen, France. HEK-Blue-2 and
HEK-Blue-4 cells are stably transfected with multiple
genes from the TLR2 and TLR4 pathways respectively,
and with a reporter gene (secreted alkaline phosphatase,
sAP) which monitors the TLR binding through NFkap-
paB activation. Cells were maintained and plated accord-
ing to manufacturers instructions. HEK-Blue-4 cells and
HEK-Blue-2 cells were then treated with various fatty
acids at different concentrations with or without 1X
Positive Control (stock 1000X, provided along with the
kit). HEK-Blue-2 and HEK-Blue-4 cells were incubated
for 16 and 20 hours respectively, followed by collection
of OD values at 640 nm.
Origin of human adipose tissue samples
Subcutaneous (abdominal, buttocks, hips and thighs) tis-
sue samples of human white fat were obtained from nor-
mal weight or slightly overweight human subjects
(exclusively females, mean body mass index = 23.3)
undergoing liposuction, performed under general anaes-
thesia, for cosmetic reasons (aged between 25 and
60 years, mean 39 years). Apart from oral contraception,
the subjects were not receiving treatment with pre-
scribed medication at the time of liposuction. A total of
8 samples were obtained and the study was approved by
the Ile de la Réunion ethics committee for the protection
of persons undergoing biomedical research.
Primary culture of human adipose tissue
The adipose tissue was rinsed thrice with Ringer-Lactate
buffer. 200 μl of tissue was distributed in 24-well tissue
culture plates with medium 199 supplemented with 1%
fatty acid free fetal bovine serum (FBS) (PAN Biotech,
France), amphotericin B, (5 mg/ml), streptomycin
(0.2 mg/ml) & penicillin (200 U/ml) (PAN Biotech,
France), 66 nM insulin (Umuline Rapide, Lilly, France),
2 g/L glucose, 8 μg/ml biotin and 4 μg/ml pantothenate.
Tissue was then maintained at 37°C in 5% CO2 for a
period of 24 hours prior to the experiments.
Primary culture of human adipocytes
Cultures were carried out as previously described [50].
Briefly after washing, tissue samples obtained by liposuc-
tion were digested for 30 min at 37°C in Ringer-Lactate
buffer containing 1.5 mg/ml collagenase (NB5, SERVA,
Germany, PZ activity 0.175 U/mg). The floating cells
(mature adipocytes) were rinsed thrice in Ringer-Lactate.
Cells were plated in 24-well (30 000 cells) or 6-well (120
000 cells) tissue culture plates with 300 μl or 1 ml
medium 199 respectively. Cells were then maintained at
37°C in 5% CO2 for a period of 24 hours prior to the
experiments.FA/BSA complex preparation and treatment
Cells and tissues were treated with complex of fatty acid
and BSA. To do this, PUFA were reconstituted in
DMSO directly and SFA were reconstituted in 0.1 N
NaOH/DMSO, heated to 70°C until it gets dissolved.
Reconstituted PUFA and SFA were then freshly conju-
gated to fatty acid free and endotoxin free BSA by incu-
bating 2 mM of each FA with 0.5 mM of BSA (4:1 molar
ratio) at 37 °C before experiments. Then they were dis-
solved directly into warmed culture medium with or
without LPS (1 μg/ml). SFA were used at 40 and
100 μM with 10 and 25 μM BSA respectively and PUFA
were used at 5 and 10 μM with 1.25 and 2.5 μM BSA re-
spectively. After 6 and 12 hours of treatment the
medium was collected and stored at -20 C for cytokine
analysis. Further to verify the above prepared SFA are
functional, adiponectin secretion and cholesterol assay
were performed (data not shown). PA was able to de-
crease adiponectin secretion while LA up-regulated this
secretion. Moreover both PA and LA induced choles-
terol uptake from media (data not shown), as it is known
for LPS treatment [51,52].IL-6, TNF-alpha and MCP-1 analysis by ELISA
Following fatty acid treatment with and without LPS
stimulation for 6 and 12 hours, media were assayed for
IL-6, TNF-alpha and MCP-1 with Ready-SET-Go human
ELISA kits (eBioscience, Cliniscience, Montrouge,
France), according to manufacturer’s instructions. ELISA
sensitivity: 4 pg/ml for TNF-alpha, 2 pg/ml for IL-6 and
7 pg/ml for MCP-1.Statistics
All values were measured as mean ± S.D. Statistical ana-
lysis was performed using Graph pad PRISM 5 software.
Differences were tested for significance, treatments ver-
sus control cells, by the one-way ANOVA and Dunnett
post-test. P < 0.05 (*) or P < 0.01 (**) or P < 0.001 (***).
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